Episurf Medical (Nasdaq: EPIS B) today announces that the abstract “Knee preservation of the middle-aged patient – two-staged treatment combination of patient specific metal implant and osteotomy. A case series.”, by Priv.-Doz. Dr. med. Clemens Kösters, has been accepted for presentation at the 11th annual congress of the Deutschen Kniegesellschaft (DKG, the German Knee Society). The congress will take place in Munich, Germany, on November 18-19, 2022.

The abstract reports on the clinical outcome for patients having undergone a two-stage treatment with a combination of Episurf Medical’s personalised knee implant Episealer®, and knee osteotomy, for treatment of chondral and osteochondral defects in the knee, at Maria-Josef-Hospital, Greven, Germany.

“We appreciate the continued interested in the clinical outcome for patients treated with our Episealer® Knee implants. This specific study is highly interesting as it is the first study with follow-up of patients who have undergone a combination of joint preserving treatment alternatives, potentially allowing treatment of more severe defects than each of the interventions alone could have treated”, says Pål Ryfors, CEO Episurf Medical.